SERPINA1 and alpha 1-antitrypsin deficiency: In 105 subjects with AAT deficiency and COVID-19 infections in 10 European countries, poor outcome was more likely with PiZZ genotype than PiSZ; interestingly, only 14 subjects were receiving regular AAT augmentation and they showed a trend toward better outcome [61].